- Home
- NVRI vs CDNA Comparison
NVRI vs CDNA Comparison
Compare NVRI & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVRI
- CDNA
- Stock Information
- Founded
- NVRI 1853
- CDNA 1998
- Country
- NVRI United States
- CDNA United States
- Employees
- NVRI N/A
- CDNA N/A
- Industry
- NVRI Diversified Commercial Services
- CDNA Medical Specialities
- Sector
- NVRI Miscellaneous
- CDNA Health Care
- Exchange
- NVRI Nasdaq
- CDNA Nasdaq
- Market Cap
- NVRI 756.7M
- CDNA 712.2M
- IPO Year
- NVRI N/A
- CDNA 2014
- Fundamental
- Price
- NVRI $11.49
- CDNA $12.83
- Analyst Decision
- NVRI
- CDNA Buy
- Analyst Count
- NVRI 0
- CDNA 6
- Target Price
- NVRI N/A
- CDNA $27.67
- AVG Volume (30 Days)
- NVRI 1.0M
- CDNA 1.3M
- Earning Date
- NVRI 08-05-2025
- CDNA 08-06-2025
- Dividend Yield
- NVRI N/A
- CDNA N/A
- EPS Growth
- NVRI N/A
- CDNA N/A
- EPS
- NVRI N/A
- CDNA 1.00
- Revenue
- NVRI $2,242,873,000.00
- CDNA $340,826,000.00
- Revenue This Year
- NVRI $0.02
- CDNA $13.02
- Revenue Next Year
- NVRI $3.71
- CDNA $12.85
- P/E Ratio
- NVRI N/A
- CDNA $12.78
- Revenue Growth
- NVRI N/A
- CDNA 14.72
- 52 Week Low
- NVRI $4.72
- CDNA $10.96
- 52 Week High
- NVRI $11.95
- CDNA $32.97
- Technical
- Relative Strength Index (RSI)
- NVRI 77.66
- CDNA 46.99
- Support Level
- NVRI $9.55
- CDNA $11.27
- Resistance Level
- NVRI $11.42
- CDNA $13.05
- Average True Range (ATR)
- NVRI 0.49
- CDNA 0.62
- MACD
- NVRI 0.23
- CDNA 0.31
- Stochastic Oscillator
- NVRI 99.69
- CDNA 90.76
About NVRI Enviri Corporation
Enviri Corp is a market-leading, provider of environmental solutions for industrial and specialty waste streams, and equipment and technology for the rail sector. The company's current operations consist of three divisions: Harsco Environmental, Harsco Rail, and Clean Earth. The company gains its revenue from Harsco Environmental segment. Geographically company operates in USA and International Countries, with majority revenue from USA.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.